Nuclear inositides: PI-PLC signaling in cell growth, differentiation and pathology

Advances in Enzyme Regulation

Volumn 49, Issue 1, 2009, Pages 2-10

  Cocco, Lucio ^a   Faenza, Irene ^a   Follo, Matilde Y ^a   Billi, Anna Maria ^a   Ramazzotti, Giulia ^a   Papa, Veronica ^a   Martelli, Alberto M ^a,b   Manzoli, Lucia ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE; ISOENZYME; PHOSPHATIDYLINOSITOL; PHOSPHOLIPASE C BETA;

ANIMAL; ARTICLE; BLOOD DISEASE; CELL DIFFERENTIATION; CELL LINE; CELL NUCLEUS; DRUG ANTAGONISM; ERYTHROLEUKEMIA; GENETICS; HUMAN; METABOLISM; MITOSIS; MYOBLAST; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL NUCLEUS; DNA MODIFICATION METHYLASES; HEMATOLOGIC NEOPLASMS; HUMANS; ISOENZYMES; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MITOSIS; MYOBLASTS; PHOSPHATIDYLINOSITOLS; PHOSPHOLIPASE C BETA; SIGNAL TRANSDUCTION;

EID: 66449123432     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.advenzreg.2008.12.001     Document Type: Article

References (71)

1. Bahk Y.Y., Lee Y.H., Lee T.G., Seo J., Ryu S.H., and Suh P.G. Two forms of phospholipase C-beta 1 generated by alternative splicing. J Biol Chem 269 (1994) 8240-8245
2. Bavelloni A., Faenza I., Cioffi G., Piazzi M., Parisi D., Matic I., et al. Proteomic-based analysis of nuclear signaling: PLCbeta1 affects the expression of the splicing factor SRp20 in Friend erythroleukemia cells. Proteomics 6 (2006) 5725-5734
3. Billi A.M., Cocco L., Martelli A.M., Gilmour R.S., and Weber G. Tiazofurin-induced changes in inositol lipid cycle in nuclei of Friend erythroleukemia cells. Biochem Biophys Res Commun 195 (1993) 8-12
4. Boronenkov I.V., Loijens J.C., Umeda M., and Anderson R.A. Phosphoinositide signaling pathways in nuclei are associated with nuclear speckles containing pre-mRNA processing factors. Mol Biol Cell 9 (1998) 3547-3560
5. Caceres J.F., Misteli T., Screaton G.R., Spector D.L., and Krainer A.R. Role of the modular domains of SR proteins in subnuclear localization and alternative splicing specificity. J Cell Biol 138 (1997) 225-238
6. Caceres J.F., Screaton G.R., and Krainer A.R. A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm. Genes Dev 12 (1998) 55-66
7. Cenciarelli C., De Santa F., Puri P.L., Mattei E., Ricci L., Bucci F., et al. Critical role played by cyclin D3 in the MyoD-mediated arrest of cell cycle during myoblast differentiation. Mol Cell Biol 19 (1999) 5203-5217
8. Cheson B.D., Greenberg P.L., Bennett J.M., Lowenberg B., Wijermans P.W., Nimer S.D., et al. Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. Blood 108 (2006) 419-425
9. Cocco L., Gilmour R.S., Ognibene A., Letcher A.J., Manzoli F.A., and Irvine R.F. Synthesis of polyphosphoinositides in nuclei of Friend cells. Evidence for polyphosphoinositide metabolism inside the nucleus which changes with cell differentiation. Biochem J 248 (1987) 765-770
10. Cocco L., Martelli A.M., Vitale M., Falconi M., Barnabei O., Gilmour R.S., et al. Inositides in the nucleus: regulation of nuclear PI-PLCbeta1. Adv Enzyme Regul 42 (2002) 181-193
11. Daskalakis M., Nguyen T.T., Nguyen C., Guldberg P., Kohler G., Wijermans P., et al. Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment. Blood 100 (2002) 2957-2964
12. Davis L., Cadrin M., Brown D.L., and Chaly N. Reversible disassembly of transcription domains in lymphocyte nuclei during inhibition of RNA synthesis by DRB. Biol Cell 78 (1993) 163-180
13. Deleris P., Bacqueville D., Gayral S., Carrez L., Salles J.P., Perret B., et al. SHIP-2 and PTEN are expressed and active in vascular smooth muscle cell nuclei, but only SHIP-2 is associated with nuclear speckles. J Biol Chem 278 (2003) 38884-38891
14. Didichenko S.A., and Thelen M. Phosphatidylinositol 3-kinase c2alpha contains a nuclear localization sequence and associates with nuclear speckles. J Biol Chem 276 (2001) 48135-48142
15. Divecha N., Banfic H., and Irvine R.F. The polyphosphoinositide cycle exists in the nuclei of Swiss 3T3 cells under the control of a receptor (for IGF-I) in the plasma membrane, and stimulation of the cycle increases nuclear diacylglycerol and apparently induces translocation of protein kinase C to the nucleus. Embo J 10 (1991) 3207-3214
16. Divecha N., Letcher A.J., Banfic H.H., Rhee S.G., and Irvine R.F. Changes in the components of a nuclear inositide cycle during differentiation in murine erythroleukaemia cells. Biochem J 312 Pt 1 (1995) 63-67
17. Evangelisti C., Riccio M., Faenza I., Zini N., Hozumi Y., Goto K., et al. Subnuclear localization and differentiation-dependent increased expression of DGK-zeta in C2C12 mouse myoblasts. J Cell Physiol 209 (2006) 370-378
18. Faenza I., Matteucci A., Manzoli L., Billi A.M., Aluigi M., Peruzzi D., et al. A role for nuclear phospholipase Cbeta 1 in cell cycle control. J Biol Chem 275 (2000) 30520-30524
19. Faenza I., Matteucci A., Bavelloni A., Marmiroli S., Martelli A.M., Gilmour R.S., et al. Nuclear PLCbeta(1) acts as a negative regulator of p45/NF-E2 expression levels in Friend erythroleukemia cells. Biochim Biophys Acta 1589 (2002) 305-310
20. Faenza I., Bavelloni A., Fiume R., Lattanzi G., Maraldi N.M., Gilmour R.S., et al. Up-regulation of nuclear PLCbeta1 in myogenic differentiation. J Cell Physiol 195 (2003) 446-452
21. Faenza I., Bavelloni A., Fiume R., Santi P., Martelli A.M., Maria Billi A., et al. Expression of phospholipase C beta family isoenzymes in C2C12 myoblasts during terminal differentiation. J Cell Physiol 200 (2004) 291-296
22. Faenza I., Ramazzotti G., Bavelloni A., Fiume R., Gaboardi G.C., Follo M.Y., et al. Inositide-dependent phospholipase C signaling mimics insulin in skeletal muscle differentiation by affecting specific regions of the cyclin D3 promoter. Endocrinology 148 (2007) 1108-1117
23. Farah C.S., and Reinach F.C. The troponin complex and regulation of muscle contraction. Faseb J 9 (1995) 755-767
24. Fiume R., Faenza I., Matteucci A., Astolfi A., Vitale M., Martelli A.M., et al. Nuclear phospholipase C beta1 (PLCbeta1) affects CD24 expression in murine erythroleukemia cells. J Biol Chem 280 (2005) 24221-24226
25. Follo M.Y., Bosi C., Finelli C., Fiume R., Faenza I., Ramazzotti G., et al. Real-time PCR as a tool for quantitative analysis of PI-PLCbeta1 gene expression in myelodysplastic syndrome. Int J Mol Med 18 (2006) 267-271
26. Follo M.Y., Mongiorgi S., Bosi C., Cappellini A., Finelli C., Chiarini F., et al. The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation. Cancer Res 67 (2007) 4287-4294
27. Follo M.Y., Finelli C., Bosi C., Martinelli G., Mongiorgi S., Baccarani M., et al. PI-PLCbeta-1 and activated Akt levels are linked to azacitidine responsiveness in high-risk myelodysplastic syndromes. Leukemia 22 (2008) 198-200
28. Follo MY, Finelli C, Clissa C, Mongiorgi S, Bosi C, Martinelli G, et al. Phosphoinositide-phospholipase C (PI-PLC) β1 mono-allelic deletion is associated with myeolodysplastic syndromes (MDS) evolution into acute myeloid leukemia (AML). J Clin Oncol in press, doi: 10.1200/JCO.2008.19.3748
29. Gruber J.R., Desai S., Blusztajn J.K., and Niles R.M. Retinoic acid specifically increases nuclear PKC alpha and stimulates AP-1 transcriptional activity in B16 mouse melanoma cells. Exp Cell Res 221 (1995) 377-384
30. Huang S., and Spector D.L. Dynamic organization of pre-mRNA splicing factors. J Cell Biochem 62 (1996) 191-197
31. Irvine R.F. Nuclear inositide signalling - expansion, structures and clarification. Biochim Biophys Acta 1761 (2006) 505-508
32. Kaminskas E., Farrell A., Abraham S., Baird A., Hsieh L.S., Lee S.L., et al. Approval summary: azacytidine for treatment of myelodysplastic syndrome subtypes. Clin Cancer Res 11 (2005) 3604-3608
33. Kato J.Y., and Sherr C.J. Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1. Proc Natl Acad Sci U S A 90 (1993) 11513-11517
34. Kim C.G., Park D., and Rhee S.G. The role of carboxyl-terminal basic amino acids in Gqalpha-dependent activation, particulate association, and nuclear localization of phospholipase C-beta1. J Biol Chem 271 (1996) 21187-21192
35. La Cour L.F., Chayen J., and Gahan P.S. Evidence for lipid material in chromosomes. Exp Cell Res 14 (1958) 469-485
36. Lallena M.J., Martinez C., Valcarcel J., and Correas I. Functional association of nuclear protein 4.1 with pre-mRNA splicing factors. J Cell Sci 111 Pt 14 (1998) 1963-1971
37. Lassar A., and Munsterberg A. Wiring diagrams: regulatory circuits and the control of skeletal myogenesis. Curr Opin Cell Biol 6 (1994) 432-442
38. Liberona J.L., Powell J.A., Shenoi S., Petherbridge L., Caviedes R., and Jaimovich E. Differences in both inositol 1,4,5-trisphosphate mass and inositol 1,4,5-trisphosphate receptors between normal and dystrophic skeletal muscle cell lines. Muscle Nerve 21 (1998) 902-909
39. Lo Vasco V.R., Calabrese G., Manzoli L., Palka G., Spadano A., Morizio E., et al. Inositide-specific phospholipase c beta1 gene deletion in the progression of myelodysplastic syndrome to acute myeloid leukemia. Leukemia 18 (2004) 1122-1126
40. Los A.P., Vinke F.P., de Widt J., Topham M.K., van Blitterswijk W.J., and Divecha N. The retinoblastoma family proteins bind to and activate diacylglycerol kinase zeta. J Biol Chem 281 (2006) 858-866
41. Manzoli F.A., Capitani S., Maraldi N.M., Cocco L., and Barnabei O. Chromatin lipids and their possible role in gene expression. A study in normal and neoplastic cells. Adv Enzyme Regul 17 (1978) 175-194
42. Manzoli F.A., Martelli A.M., Capitani S., Maraldi N.M., Rizzoli R., Barnabei O., et al. Nuclear polyphosphoinositides during cell growth and differentiation. Adv Enzyme Regul 28 (1989) 25-34
43. Manzoli L., Billi A.M., Gilmour R.S., Martelli A.M., Matteucci A., Rubbini S., et al. Phosphoinositide signaling in nuclei of Friend cells: tiazofurin down-regulates phospholipase C beta 1. Cancer Res 55 (1995) 2978-2980
44. Manzoli L., Billi A.M., Rubbini S., Bavelloni A., Faenza I., Gilmour R.S., et al. Essential role for nuclear phospholipase C beta1 in insulin-like growth factor I-induced mitogenesis. Cancer Res 57 (1997) 2137-2139
45. Mariappan I., and Parnaik V.K. Sequestration of pRb by cyclin D3 causes intranuclear reorganization of lamin A/C during muscle cell differentiation. Mol Biol Cell 16 (2005) 1948-1960
46. Martelli A.M., Gilmour R.S., Bertagnolo V., Neri L.M., Manzoli L., and Cocco L. Nuclear localization and signalling activity of phosphoinositidase C beta in Swiss 3T3 cells. Nature 358 (1992) 242-245
47. Martelli A.M., Billi A.M., Gilmour R.S., Neri L.M., Manzoli L., Ognibene A., et al. Phosphoinositide signaling in nuclei of Friend cells: phospholipase C beta down-regulation is related to cell differentiation. Cancer Res 54 (1994) 2536-2540
48. Martelli A.M., Tabellini G., Bortul R., Manzoli L., Bareggi R., Baldini G., et al. Enhanced nuclear diacylglycerol kinase activity in response to a mitogenic stimulation of quiescent Swiss 3T3 cells with insulin-like growth factor I. Cancer Res 60 (2000) 815-821
49. Matteucci A., Faenza I., Gilmour R.S., Manzoli L., Billi A.M., Peruzzi D., et al. Nuclear but not cytoplasmic phospholipase C beta 1 inhibits differentiation of erythroleukemia cells. Cancer Res 58 (1998) 5057-5060
50. Mortillaro M.J., Blencowe B.J., Wei X., Nakayasu H., Du L., Warren S.L., et al. A hyperphosphorylated form of the large subunit of RNA polymerase II is associated with splicing complexes and the nuclear matrix. Proc Natl Acad Sci U S A 93 (1996) 8253-8257
51. Neri L.M., Borgatti P., Capitani S., and Martelli A.M. Nuclear diacylglycerol produced by phosphoinositide-specific phospholipase C is responsible for nuclear translocation of protein kinase C-alpha. J Biol Chem 273 (1998) 29738-29744
52. Odom A.R., Stahlberg A., Wente S.R., and York J.D. A role for nuclear inositol 1,4,5-trisphosphate kinase in transcriptional control. Science 287 (2000) 2026-2029
53. Osborne S.L., Thomas C.L., Gschmeissner S., and Schiavo G. Nuclear PtdIns(4,5)P2 assembles in a mitotically regulated particle involved in pre-mRNA splicing. J Cell Sci 114 (2001) 2501-2511
54. Payrastre B., Nievers M., Boonstra J., Breton M., Verkleij A.J., and Van Bergen en Henegouwen P.M. A differential location of phosphoinositide kinases, diacylglycerol kinase, and phospholipase C in the nuclear matrix. J Biol Chem 267 (1992) 5078-5084
55. Pombo A., and Cook P.R. The localization of sites containing nascent RNA and splicing factors. Exp Cell Res 229 (1996) 201-203
56. Ramazzotti G., Faenza I., Gaboardi G.C., Piazzi M., Bavelloni A., Fiume R., et al. Catalytic activity of nuclear PLC-beta(1) is required for its signalling function during C2C12 differentiation. Cell Signal 20 11 (2008 Nov) 2013-2021
57. Rebecchi M.J., and Pentyala S.N. Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol Rev 80 (2000) 1291-1335
58. Ross E.M., Mateu D., Gomes A.V., Arana C., Tran T., and Litosch I. Structural determinants for phosphatidic acid regulation of phospholipase C-beta1. J Biol Chem 281 (2006) 33087-33094
59. Saeki K., Yasugi E., Okuma E., Breit S.N., Nakamura M., Toda T., et al. Proteomic analysis on insulin signaling in human hematopoietic cells: identification of CLIC1 and SRp20 as novel downstream effectors of insulin. Am J Physiol Endocrinol Metab 289 (2005) E419-E428
60. Schmalz D., Kalkbrenner F., Hucho F., and Buchner K. Transport of protein kinase C alpha into the nucleus requires intact cytoskeleton while the transport of a protein containing a canonical nuclear localization signal does not. J Cell Sci 109 Pt 9 (1996) 2401-2406
61. Schmalz D., Hucho F., and Buchner K. Nuclear import of protein kinase C occurs by a mechanism distinct from the mechanism used by proteins with a classical nuclear localization signal. J Cell Sci 111 Pt 13 (1998) 1823-1830
62. Silverman L.R., Demakos E.P., Peterson B.L., Kornblith A.B., Holland J.C., Odchimar-Reissig R., et al. Randomized controlled trial of azacytidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. J Clin Oncol 20 (2002) 2429-2440
63. Soh J.W., and Weinstein I.B. Roles of specific isoforms of protein kinase C in the transcriptional control of cyclin D1 and related genes. J Biol Chem 278 (2003) 34709-34716
64. Spector D.L. Macromolecular domains within the cell nucleus. Annu Rev Cell Biol 9 (1993) 265-315
65. Spector D.L., Schrier W.H., and Busch H. Immunoelectron microscopic localization of snRNPs. Biol Cell 49 (1983) 1-10
66. Spector D.L., Fu X.D., and Maniatis T. Associations between distinct pre-mRNA splicing components and the cell nucleus. Embo J 10 (1991) 3467-3481
67. Tabellini G., Bortul R., Santi S., Riccio M., Baldini G., Cappellini A., et al. Diacylglycerol kinase-theta is localized in the speckle domains of the nucleus. Exp Cell Res 287 (2003) 143-154
68. Wang Z., Sicinski P., Weinberg R.A., Zhang Y., and Ravid K. Characterization of the mouse cyclin D3 gene: exon/intron organization and promoter activity. Genomics 35 (1996) 156-163
69. York J.D., Odom A.R., Murphy R., Ives E.B., and Wente S.R. A phospholipase C-dependent inositol polyphosphate kinase pathway required for efficient messenger RNA export. Science 285 (1999) 96-100
70. Yu H., Fukami K., Watanabe Y., Ozaki C., and Takenawa T. Phosphatidylinositol 4,5-bisphosphate reverses the inhibition of RNA transcription caused by histone H1. Eur J Biochem 251 (1998) 281-287
71. Zhao K., Wang W., Rando O.J., Xue Y., Swiderek K., Kuo A., et al. Rapid and phosphoinositol-dependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling. Cell 95 (1998) 625-636